Lee et al. [23]
|
2018
|
Meta-analysis
|
Medline, Embase, Cochrane
|
20
|
1,333 patients and 1,048 controls
|
Inclusion criteria: case-control, cross-sectional, or cohort studies with data on serum/plasma leptin levels in case and control groups. No language and race restrictions. Exclusion criteria: overlapping or insufficient data, reviews, and case reports
|
Leptin levels were elevated in SLE patients regardless of ethnicity, data type, sample size, and matched variables. The study proposed that leptin may have an important role in the pathogenesis of SLE, but the exact mechanism is not clear
|
No external funding
|
Yuan et al. [4]
|
2020
|
Systematic review and meta-analysis
|
PubMed, Embase, Cochrane, China National Knowledge Infrastructure, China WanFang, China Weipu
|
34
|
1,744 patients and 1,411 controls
|
Inclusion criteria: cohort, case-control, and cross-sectional studies with data on the serum/plasma leptin levels, leptin receptor levels, and relevant gene polymorphism in case and control groups, studies with predefined SLE criteria and measurement methods, studies with OR estimates with 95% CI and p-values. Exclusion criteria: case reports, editorials, letters, comments, review articles, meta-analysis, and non-human subjects
|
Leptin levels were higher in SLE patients regardless of source, sample size, or assay method. In terms of ethnicity, leptin levels were elevated in Asian, African, North American, and European groups. SLE patients showed a decreased trend of leptin receptor levels
|
Received external funding
|